Supreme Court: Foreign Companies’ Head Office Expenses in India are Capped under Section 44C  ||  SC Directs Trial Courts to Systematically Catalogue Witnesses and Evidence in Criminal Judgments  ||  SC Calls For Sensitising Future Generations on Equality in Marriage to Combat Dowry Practices  ||  SC: Separate Suits Against Confirmed Auction Sales are Barred; Remedy Available under Sec 47  ||  NCLT Mumbai: Oppression Claims Against Majority Shareholders Do not Justify Winding up a Company  ||  J&K&L HC Rules it Illegal and Inequitable to Deny Regularisation to a Daily Wager After 34 Years  ||  J&K&L High Court: Revisional Powers Must Be Used Within Reasonable Time; Merits Don’t Justify Delay  ||  Supreme Court: Compassionate Appointees Cannot Later Claim Entitlement to a Higher Post  ||  NCLAT New Delhi: Insolvency Pleas Cannot Be Admitted When Information Utility Records Show a Dispute  ||  NCLAT: Issuing Cheques For Another Entity’s Liabilities Does not Constitute Operational Debt    

Delhi High Court Awards Natco Pharma Interim Relief in BMS Patents Case - (23 Jul 2019)

INTELLECTUAL PROPERTY RIGHTS

Delhi High Court has awarded interim relief to the Hyderabad-based Natco Pharma Ltd in a fresh patents battle, with the court setting aside an injunction petition filed by Bristol-Myers Squibb seeking to protect its anti-coagulant Apixaban against Natco’s Apigat.

Tags : DELHI HIGH COURT   NATCO PHARMA  

Share :        

Disclaimer | Copyright 2025 - All Rights Reserved